EUCTR2010-019519-39-NL进行中（未招募）不适用
Efficacy of RAD001/everolimus in Autism and NeuroPsychological deficits in children with TSC (RAPIT-trial) - RAPIT
Erasmus MC - Department of Neurology0 个研究点开始时间: 2011年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children with a definite diagnosis of TSC between 3 and 18 years.
- •With an IQ estimated <80 and/or special schooling and/or autism spectrum disorder and/or learning disability
- •requiring remedial teaching.
- •Written informed consent by parents/care-takers, and the patient if he or she is 12 years or older and cognitively
- •able to consent.
- •In girls after menarche, appropriate contraception must be used or abstinence practiced.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 60
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Renal or liver dysfunction
- •Surgery <6wk before entering the study
- •Current infection at time of inclusion
- •Additional diseases or disorders that may influence the endpoints
- •Allergy for any of the components of the study medication
研究者
相似试验
已完成
2 期
Efficacy of RAD001/everolimus in Autism and NeuroPsychological deficits in children with TSC (RAPIT-trial)NL-OMON39487Erasmus MC, Universitair Medisch Centrum Rotterdam60
Unknown
2 期
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis ComplexTuberous Sclerosis ComplexTSC Related Cognitive DisabilityTSC Related AutismTSC Related Learning ProblemsNCT01730209Erasmus Medical Center60
已完成
不适用
study of everolimus for autistic spectrum disorder in tuberous sclerosistuberous sclerosisJPRN-UMIN000024270niversity of Tsukuba3
进行中（未招募）
不适用
Efficacy and Safety of RAD001 (Everolimus) in Patients Affected by Biliary Tract Cancer Progressing After Prior Chemotherapy: a Phase II I.T.M.O. Study - Everolimus in biliary tract cancerPatients affected by biliary tract cancer progressing after prior chemotherapyMedDRA version: 9.1Level: LLTClassification code 10055111Term: Biliary cancer metastaticEUCTR2008-007152-94-ITI.T.M.O. - ITALIAN TRIALS IN MEDICAL ONCOLOGY
进行中（未招募）
1 期
Evaluation of allopurinol treatment for autistic disorders and epilepsy in adenylosuccinate lyase deficiency (ADSL)EUCTR2017-002155-28-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)8